Compare Repligen Corporation Common Stock (RGEN) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Riot Platforms Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Riot Platforms Inc trades at $14.62 (market cap $5.66B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Riot Platforms Inc for 16 Days on average.
| RGEN | RIOT | |
|---|---|---|
Market Cap | $11.31B | $5.66B |
Volume | 1,216,919 | 21,816,889 |
Sector | Health | Financials |
52-Week High | $194.57 | $28.67 |
52-Week Low | $102.87 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $11.20B | $6.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
RIOT Platforms trades at $16.67, up 1.21% with a bearish technical signal despite bullish oscillators. The company reported significant losses with a net income margin of -196.28% and negative cash flow from operations of -$573 million in 2025. Recent strategic shift to data center leasing secured $9.8 billion in contracted revenue through 2048, attracting major tenants like AMD.
Analyst consensus remains strongly bullish with 94.74% buy ratings and a $31.64 price target, suggesting substantial upside potential. Key risks include persistent negative profitability, high valuation multiples, and execution challenges in the AI infrastructure transition. The stock faces near-term pressure from consecutive earnings misses but offers long-term growth potential through its power capacity assets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
